Cardioprotection Effects of LPTC‑5 Involve Mitochondrial Protection and Dynamics
Related Experiment Video
Updated: Nov 5, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Wei Bi1, Yue Bi1, Pengfei Li1
1Second Hospital of HeBei Medical University, Shijiazhuang 050000, PR China.
Abstract:
We recently designed and synthesized a series of novel levodopa-peptide-TEMPO conjugates (LPTCs). Among these compounds, LPTC-5 possesses both free-radical scavenging potential and mitochondrial fusion-promoting activity. The free-radical scavenging capacity of LPTC-5 was confirmed using a PC12 cell survival assay. LPTC-5 could restore the mitochondrial tubular network following genetically induced fragmentation. The therapeutic efficacy of LPTC-5 was then examined employing in vitro and in vivo ischemia/reperfusion (I/R) models. LPTC-5 protected cells from mitochondrial reactive oxygen species overproduction and inhibited cytochrome c release in a simulated I/R cellular model. Additionally, LPTC-5 attenuated organ damage in a cardiac I/R animal model. The data suggest that LPTC-5 exerts cardioprotection via modulation of mitochondrial fission/fusion dynamics, ultimately improving mitochondrial function and cardiac function.
Related Concept Videos
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
